|
||||||
|
 | Fusion Gene Summary |
| Fusion Gene ORF analysis |
| Fusion Genomic Features |
| Fusion Protein Features |
| Fusion Gene Sequence |
| Fusion Gene PPI analysis |
| Related Drugs |
| Related Diseases |
Fusion gene:ARHGEF25-CPNE8 (FusionGDB2 ID:6263) |
Fusion Gene Summary for ARHGEF25-CPNE8 |
 Fusion gene summary |
| Fusion gene information | Fusion gene name: ARHGEF25-CPNE8 | Fusion gene ID: 6263 | Hgene | Tgene | Gene symbol | ARHGEF25 | CPNE8 | Gene ID | 115557 | 144402 |
| Gene name | Rho guanine nucleotide exchange factor 25 | copine 8 | |
| Synonyms | GEFT|p63RhoGEF | - | |
| Cytomap | 12q13.3 | 12q12 | |
| Type of gene | protein-coding | protein-coding | |
| Description | rho guanine nucleotide exchange factor 25RAC/CDC42 exchange factorRho guanine nucleotide exchange factor (GEF) 25RhoA/RAC/CDC42 exchange factorguanine nucleotide exchange factor GEFTrac/Cdc42/Rho exchange factor GEFTrhoA/Rac/Cdc42 guanine nucleotide | copine-8copine VIII | |
| Modification date | 20200313 | 20200313 | |
| UniProtAcc | Q86VW2 | Q86YQ8 | |
| Ensembl transtripts involved in fusion gene | ENST00000286494, ENST00000333972, ENST00000477314, | ENST00000360449, ENST00000546603, ENST00000331366, ENST00000538596, | |
| Fusion gene scores | * DoF score | 3 X 3 X 2=18 | 7 X 5 X 6=210 |
| # samples | 3 | 7 | |
| ** MAII score | log2(3/18*10)=0.736965594166206 effective Gene in Pan-Cancer Fusion Genes (eGinPCFGs). DoF>8 and MAII>0 | log2(7/210*10)=-1.58496250072116 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
| Context | PubMed: ARHGEF25 [Title/Abstract] AND CPNE8 [Title/Abstract] AND fusion [Title/Abstract] | ||
| Most frequent breakpoint | ARHGEF25(58008183)-CPNE8(39047872), # samples:2 | ||
| Anticipated loss of major functional domain due to fusion event. | ARHGEF25-CPNE8 seems lost the major protein functional domain in Hgene partner, which is a essential gene due to the frame-shifted ORF. | ||
| * DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
| Gene ontology of each fusion partner gene with evidence of Inferred from Direct Assay (IDA) from Entrez |
| Partner | Gene | GO ID | GO term | PubMed ID |
| Fusion gene breakpoints across ARHGEF25 (5'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene breakpoints across CPNE8 (3'-gene) * Click on the image to open the UCSC genome browser with custom track showing this image in a new window. |
 |
| Fusion gene information from two resources (ChiTars 5.0 and ChimerDB 4.0) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| Source | Disease | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| ChimerDB4 | SARC | TCGA-DX-AB2H-01A | ARHGEF25 | chr12 | 58008183 | - | CPNE8 | chr12 | 39047872 | - |
| ChimerDB4 | SARC | TCGA-DX-AB2H-01A | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
Top |
Fusion Gene ORF analysis for ARHGEF25-CPNE8 |
| Open reading frame (ORF) analsis of fusion genes based on Ensembl gene isoform structure. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
| ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
| 5CDS-5UTR | ENST00000286494 | ENST00000360449 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| 5CDS-5UTR | ENST00000286494 | ENST00000546603 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| 5CDS-5UTR | ENST00000333972 | ENST00000360449 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| 5CDS-5UTR | ENST00000333972 | ENST00000546603 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| Frame-shift | ENST00000286494 | ENST00000331366 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| Frame-shift | ENST00000333972 | ENST00000331366 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| In-frame | ENST00000286494 | ENST00000538596 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| In-frame | ENST00000333972 | ENST00000538596 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| intron-3CDS | ENST00000477314 | ENST00000331366 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| intron-3CDS | ENST00000477314 | ENST00000538596 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| intron-5UTR | ENST00000477314 | ENST00000360449 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| intron-5UTR | ENST00000477314 | ENST00000546603 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - |
| ORFfinder result based on the fusion transcript sequence of in-frame fusion genes. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | Seq length (transcript) | BP loci (transcript) | Predicted start (transcript) | Predicted stop (transcript) | Seq length (amino acids) |
| ENST00000333972 | ARHGEF25 | chr12 | 58008183 | + | ENST00000538596 | CPNE8 | chr12 | 39047872 | - | 2593 | 880 | 7 | 1068 | 353 |
| ENST00000286494 | ARHGEF25 | chr12 | 58008183 | + | ENST00000538596 | CPNE8 | chr12 | 39047872 | - | 2899 | 1186 | 415 | 1374 | 319 |
| DeepORF prediction of the coding potential based on the fusion transcript sequence of in-frame fusion genes. DeepORF is a coding potential classifier based on convolutional neural network by comparing the real Ribo-seq data. If the no-coding score < 0.5 and coding score > 0.5, then the in-frame fusion transcript is predicted as being likely translated. |
| Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | No-coding score | Coding score |
| ENST00000333972 | ENST00000538596 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - | 0.000600046 | 0.9993999 |
| ENST00000286494 | ENST00000538596 | ARHGEF25 | chr12 | 58008183 | + | CPNE8 | chr12 | 39047872 | - | 0.001136446 | 0.9988636 |
Top |
Fusion Genomic Features for ARHGEF25-CPNE8 |
| FusionAI prediction of the potential fusion gene breakpoint based on the pre-mature RNA sequence context (+/- 5kb of individual partner genes, total 20kb length sequence). FusionAI is a fusion gene breakpoint classifier based on convolutional neural network by comparing the fusion positive and negative sequence context of ~ 20K fusion gene data. From here, we can have the relative potentency of the 20K genomic sequence how individual sequnce will be likely used as the gene fusion breakpoints. |
| Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand | 1-p | p (fusion gene breakpoint) |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions. We integrated a total of 44 different types of human genomic feature loci information across five big categories including virus integration sites, repeats, structural variants, chromatin states, and gene expression regulation. More details are in help page. |
 |
| Distribution of 44 human genomic features loci across 20kb length fusion breakpoint regions that are ovelapped with the top 1% feature importance score regions. More details are in help page. |
Top |
Fusion Protein Features for ARHGEF25-CPNE8 |
| Four levels of functional features of fusion genes Go to FGviewer search page for the most frequent breakpoint (https://ccsmweb.uth.edu/FGviewer/chr12:58008183/chr12:39047872) - FGviewer provides the online visualization of the retention search of the protein functional features across DNA, RNA, protein, and pathological levels. - How to search 1. Put your fusion gene symbol. 2. Press the tab key until there will be shown the breakpoint information filled. 4. Go down and press 'Search' tab twice. 4. Go down to have the hyperlink of the search result. 5. Click the hyperlink. 6. See the FGviewer result for your fusion gene. |
 |
| Main function of each fusion partner protein. (from UniProt) |
| Hgene | Tgene |
| ARHGEF25 | CPNE8 |
| FUNCTION: May play a role in actin cytoskeleton reorganization in different tissues since its activation induces formation of actin stress fibers. It works as a guanine nucleotide exchange factor for Rho family of small GTPases. Links specifically G alpha q/11-coupled receptors to RHOA activation. May be an important regulator of processes involved in axon and dendrite formation. In neurons seems to be an exchange factor primarily for RAC1. Involved in skeletal myogenesis (By similarity). {ECO:0000250, ECO:0000269|PubMed:11861769, ECO:0000269|PubMed:12547822, ECO:0000269|PubMed:15069594, ECO:0000269|PubMed:15632174, ECO:0000269|PubMed:16314529, ECO:0000269|PubMed:17606614}. | FUNCTION: Probable calcium-dependent phospholipid-binding protein that may play a role in calcium-mediated intracellular processes. {ECO:0000250|UniProtKB:Q99829}. |
| Retention analysis result of each fusion partner protein across 39 protein features of UniProt such as six molecule processing features, 13 region features, four site features, six amino acid modification features, two natural variation features, five experimental info features, and 3 secondary structure features. Here, because of limited space for viewing, we only show the protein feature retention information belong to the 13 regional features. All retention annotation result can be downloaded at * Minus value of BPloci means that the break pointn is located before the CDS. |
| - In-frame and retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| - In-frame and not-retained protein feature among the 13 regional features. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000286494 | + | 7 | 15 | 160_336 | 242 | 581.0 | Domain | DH |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000286494 | + | 7 | 15 | 348_466 | 242 | 581.0 | Domain | PH |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000333972 | + | 8 | 16 | 160_336 | 281 | 620.0 | Domain | DH |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000333972 | + | 8 | 16 | 348_466 | 281 | 620.0 | Domain | PH |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000286494 | + | 7 | 15 | 278_299 | 242 | 581.0 | Region | Note=Important for binding to Rho GTPases |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000286494 | + | 7 | 15 | 467_493 | 242 | 581.0 | Region | Note=Sufficient to bind activated GNAQ |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000333972 | + | 8 | 16 | 278_299 | 281 | 620.0 | Region | Note=Important for binding to Rho GTPases |
| Hgene | ARHGEF25 | chr12:58008183 | chr12:39047872 | ENST00000333972 | + | 8 | 16 | 467_493 | 281 | 620.0 | Region | Note=Sufficient to bind activated GNAQ |
| Tgene | CPNE8 | chr12:58008183 | chr12:39047872 | ENST00000331366 | 18 | 20 | 142_265 | 502 | 565.0 | Domain | C2 2 | |
| Tgene | CPNE8 | chr12:58008183 | chr12:39047872 | ENST00000331366 | 18 | 20 | 1_133 | 502 | 565.0 | Domain | C2 1 | |
| Tgene | CPNE8 | chr12:58008183 | chr12:39047872 | ENST00000331366 | 18 | 20 | 309_510 | 502 | 565.0 | Domain | VWFA |
Top |
Fusion Gene Sequence for ARHGEF25-CPNE8 |
| For in-frame fusion transcripts, we provide the fusion transcript sequences and fusion amino acid sequences. To have fusion amino acid sequence, we ran ORFfinder and chose the longest ORF among the all predicted ones. |
| >6263_6263_1_ARHGEF25-CPNE8_ARHGEF25_chr12_58008183_ENST00000286494_CPNE8_chr12_39047872_ENST00000538596_length(transcript)=2899nt_BP=1186nt ATTCAGCTCTCCGCTCCGCTGGGACCCGCACAGCGCCAGTGGCTCGGGGGTCGGCCCTCGCCTCCTCCCCGGCCCGGGCCTAGAGCCACC CCTAACCAGAGGCCGGAGACAGCTGGAGCGGCTGCCGCATCCCGGCCCAGCCTCCCCTACCATCCCTCCCCCTTCCACTGGACATCTGGA CCCTAGGCCCCCGCACCGACAGGGTTCCGGAAACCCTCCCCGCCCAGCCCGGCGGCCGGGCCCCGCGCCTCTCTCTCTCTAGAGCCCCCA GCCCTCCTCAAGACTAGACTTCCGCCTACCCCTGGACACCTCCTCCCGGTCCCCTCCCTCCCCCCCTCCCACAGCCTGGACCGGGGTAGG AGGGAGGGGGGGTGTGCGCCCGGCGCCGTCCCCGCCCCGCCCCCCGTGATTCCCCCTGCATGGCCGGCCCGGGTGGGGGGCGCGGGGGGG CCCGGGCGCCATGCGGGGGGGGCACAAAGGGGGTCGCTGTGCCTGTCCCCGTGTGATCCGAAAAGTGCTGGCAAAATGCGGCTGCTGCTT CGCCCGGGGGGGACGTGAATCCTATTCCATTGCGGGCAGTGAGGGGAGTATATCGGCTTCTGCTGCCTCCGGTCTGGCTGCCCCCTCTGG CCCCAGCTCTGGCCTCAGCTCTGGCCCCTGTTCCCCAGGCCCCCCAGGGCCCGTCAGTGGCCTGAGGAGATGGTTGGATCATTCCAAACA TTGTCTCAGTGTGGAAACTGAGGCAGACAGTGGTCAGGCAGGACCATATGAGAACTGGATGTTGGAGCCAGCTCTAGCCACAGGAGAGGA GCTGCCGGAACTGACCTTGCTGACCACACTGTTGGAGGGCCCTGGAGATAAGACGCAGCCACCTGAAGAGGAGACTTTGTCCCAAGCCCC TGAGAGTGAGGAGGAACAGAAGAAGAAGGCTCTGGAAAGGAGTATGTATGTCCTGAGTGAACTGGTAGAAACAGAGAAAATGTACGTGGA CGACTTGGGGCAGATTGTGGAGGGTTATATGGCCACCATGGCTGCTCAGGGGGTCCCCGAGAGTCTTCGAGGCCGTGACAGGATTGTGTT TGGGAATATCCAGCAAATCTATGAGTGGCACCGAGACTATTTCTTGCAAGAGCTACAACGGTGTCTGAAAGATCCTGATTGGCTGGCTCA GCTATTCATCAAACACTTTGTGCCATTCAGGGATTATATTGACAGAAGTGGAAACCACATACTGAGCATGGCTAGATTGGCTAAAGATGT CCTAGCTGAGATCCCTGAGCAGTTTCTCTCCTATATGAGAGCCCGAGGAATCAAGCCATCACCTGCGCCTCCCCCATACACCCCACCTAC ACATGTGTTACAGACTCAAATATGACTGTGCTCTGAAATGCTAATGTCAACTACAAATCAAAAGTGCTGAGTTAATGCTTTGTGCCTGGT GCTCTGTAATGAACCAGGCAATGAGATAGTTTTCTCAGTTTGGTTTCAGCAGTTAATGTGCTTTCTTGGATCCAAATTTAAATATCTTCC TAAACCAAAACTGTAAATATGGTTGTTGCATGAGCAACAGAAAAAATTGTTTAAATGCTTGAAGCAAAGTATGGATGTCTTCTCTAAATC TTTCTTTCTTTTTTTTTTTAACAGAAACAGCTAATTTCCAATGTATTGTTGGGAAAAAGCACAAACTGTGTTTTTAACTCAAATATTGTC TTCGACTGCTATGTGTATAGGAAAGCAGTCTCTGTATCAATGTTTACATGTTACTACTTTTTAAATTTCAATACTTTTATAACTGTTCTT AAAAATAAGAGTTTTAAATACTGAATCCTTTGTCTTCTAAATTGCAATAGCTATAATCACAAGAGCAATATCTCTTTGAATGACTGTCTG GACAAACACAATTGCAAATAAGGGAAGGGAAAAATGCTTTTCTATTTTTCAGTAACTGGATTGTCTTAAGAAACTACATCTGCTTAATAA ACAATTTCTCAGCAATGTTTGCTGGGTATGGGAGTTTAAGCCCGGCAGATGTGTCTCCTGGTTGAACATGCATTTTTCATGGAGTTTGGG TTCTAAATTTAGACTGCAGTTGGTTTGTATTTTGTAACACTAAGTAGAAATTATAAAAAGTCAAACATTGTGATCTATAAATGCACAGAA AATACTTTGTAAAAAGTAGCATCCTTATATAATAATGCTATTTAGAAAGACTGAAACCAAGACTATTTAACTGTGAACTATGTAGCAGAT GTTTTAAACTTTTTATTCCATTATATCTTGTCTAGATATTTTAATTCAAAGGGATACTGGCTCTCTTGATCGGAATTTCTTGTTATCACC ATTCCACGTTGCCACACAAGGTGCACAGGCTGGAAGTCTTTTGTGAAATTCCCAGTTAAATATATACAACTATGTGACTTAGTGCACAAC ACATTTGTGAAATAACCTACTCCTATATACTGACCTGCCTGTCCACGAATAATTGTAAAGGGTTTTTGCATGTACAGTTTTTACAAGAAT TACAGTTTTGTGAAGTTGTGTCTAAATTAAAGCATTTCTTTAGAACAAATGGCCTTAAATTCTCACGGAATTCCTGGAAATGATTGTGAA TTGCCTTCAAATAATAGAAAAGTGTATTTATTTGTGTGTGTGTGTGTGTCAAAAATGTAACTGCTTTATAATATTTTTTCCTTACCTATA TATTCTATTTAATACTTGGTTTATTTCTACTGTACATTGTTTTCTTTGTCCCAAGTTGACCTAGGGTGACTTTTATAAGCATGAAACTAT TTTACTGGAAAGAAAAATATATACATCCACATATCTAACAGTATCAATGTTATATAACTATGTAATAATTGTTGATTTTTAATTATGTAT >6263_6263_1_ARHGEF25-CPNE8_ARHGEF25_chr12_58008183_ENST00000286494_CPNE8_chr12_39047872_ENST00000538596_length(amino acids)=319AA_BP=257 MHGRPGWGARGGPGAMRGGHKGGRCACPRVIRKVLAKCGCCFARGGRESYSIAGSEGSISASAASGLAAPSGPSSGLSSGPCSPGPPGPV SGLRRWLDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGPGDKTQPPEEETLSQAPESEEEQKKKALERSMYVL SELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYFLQELQRCLKDPDWLAQLFIKHFVPFRDYIDRSGN -------------------------------------------------------------- >6263_6263_2_ARHGEF25-CPNE8_ARHGEF25_chr12_58008183_ENST00000333972_CPNE8_chr12_39047872_ENST00000538596_length(transcript)=2593nt_BP=880nt CTCGACCCTGAAACTTGGAGCAGGGTGGGGGTTCAGTATGAAGCCCCCGGACCGCCCCGCCCCTGGCCGCACTGACCGGATACTGGGGGT CATGGGGGGCATGCTGCGCGCATGCGCCCTCCCTGGGCAGGAGGGGCCCCCAAGGAGAAGCCCTCTAGGGTTGGTGGGTACCGAGCCAGA GTCTGAACGTACGGAGGGAGATCACAGAAGGGATCGCGAACATGAGGTCCTCGCCGGGGCTCTGCAGCCCGAATCCTATTCCATTGCGGG CAGTGAGGGGAGTATATCGGCTTCTGCTGCCTCCGGTCTGGCTGCCCCCTCTGGCCCCAGCTCTGGCCTCAGCTCTGGCCCCTGTTCCCC AGGCCCCCCAGGGCCCGTCAGTGGCCTGAGGAGATGGTTGGATCATTCCAAACATTGTCTCAGTGTGGAAACTGAGGCAGACAGTGGTCA GGCAGGACCATATGAGAACTGGATGTTGGAGCCAGCTCTAGCCACAGGAGAGGAGCTGCCGGAACTGACCTTGCTGACCACACTGTTGGA GGGCCCTGGAGATAAGACGCAGCCACCTGAAGAGGAGACTTTGTCCCAAGCCCCTGAGAGTGAGGAGGAACAGAAGAAGAAGGCTCTGGA AAGGAGTATGTATGTCCTGAGTGAACTGGTAGAAACAGAGAAAATGTACGTGGACGACTTGGGGCAGATTGTGGAGGGTTATATGGCCAC CATGGCTGCTCAGGGGGTCCCCGAGAGTCTTCGAGGCCGTGACAGGATTGTGTTTGGGAATATCCAGCAAATCTATGAGTGGCACCGAGA CTATTTCTTGCAAGAGCTACAACGGTGTCTGAAAGATCCTGATTGGCTGGCTCAGCTATTCATCAAACACTTTGTGCCATTCAGGGATTA TATTGACAGAAGTGGAAACCACATACTGAGCATGGCTAGATTGGCTAAAGATGTCCTAGCTGAGATCCCTGAGCAGTTTCTCTCCTATAT GAGAGCCCGAGGAATCAAGCCATCACCTGCGCCTCCCCCATACACCCCACCTACACATGTGTTACAGACTCAAATATGACTGTGCTCTGA AATGCTAATGTCAACTACAAATCAAAAGTGCTGAGTTAATGCTTTGTGCCTGGTGCTCTGTAATGAACCAGGCAATGAGATAGTTTTCTC AGTTTGGTTTCAGCAGTTAATGTGCTTTCTTGGATCCAAATTTAAATATCTTCCTAAACCAAAACTGTAAATATGGTTGTTGCATGAGCA ACAGAAAAAATTGTTTAAATGCTTGAAGCAAAGTATGGATGTCTTCTCTAAATCTTTCTTTCTTTTTTTTTTTAACAGAAACAGCTAATT TCCAATGTATTGTTGGGAAAAAGCACAAACTGTGTTTTTAACTCAAATATTGTCTTCGACTGCTATGTGTATAGGAAAGCAGTCTCTGTA TCAATGTTTACATGTTACTACTTTTTAAATTTCAATACTTTTATAACTGTTCTTAAAAATAAGAGTTTTAAATACTGAATCCTTTGTCTT CTAAATTGCAATAGCTATAATCACAAGAGCAATATCTCTTTGAATGACTGTCTGGACAAACACAATTGCAAATAAGGGAAGGGAAAAATG CTTTTCTATTTTTCAGTAACTGGATTGTCTTAAGAAACTACATCTGCTTAATAAACAATTTCTCAGCAATGTTTGCTGGGTATGGGAGTT TAAGCCCGGCAGATGTGTCTCCTGGTTGAACATGCATTTTTCATGGAGTTTGGGTTCTAAATTTAGACTGCAGTTGGTTTGTATTTTGTA ACACTAAGTAGAAATTATAAAAAGTCAAACATTGTGATCTATAAATGCACAGAAAATACTTTGTAAAAAGTAGCATCCTTATATAATAAT GCTATTTAGAAAGACTGAAACCAAGACTATTTAACTGTGAACTATGTAGCAGATGTTTTAAACTTTTTATTCCATTATATCTTGTCTAGA TATTTTAATTCAAAGGGATACTGGCTCTCTTGATCGGAATTTCTTGTTATCACCATTCCACGTTGCCACACAAGGTGCACAGGCTGGAAG TCTTTTGTGAAATTCCCAGTTAAATATATACAACTATGTGACTTAGTGCACAACACATTTGTGAAATAACCTACTCCTATATACTGACCT GCCTGTCCACGAATAATTGTAAAGGGTTTTTGCATGTACAGTTTTTACAAGAATTACAGTTTTGTGAAGTTGTGTCTAAATTAAAGCATT TCTTTAGAACAAATGGCCTTAAATTCTCACGGAATTCCTGGAAATGATTGTGAATTGCCTTCAAATAATAGAAAAGTGTATTTATTTGTG TGTGTGTGTGTGTCAAAAATGTAACTGCTTTATAATATTTTTTCCTTACCTATATATTCTATTTAATACTTGGTTTATTTCTACTGTACA TTGTTTTCTTTGTCCCAAGTTGACCTAGGGTGACTTTTATAAGCATGAAACTATTTTACTGGAAAGAAAAATATATACATCCACATATCT >6263_6263_2_ARHGEF25-CPNE8_ARHGEF25_chr12_58008183_ENST00000333972_CPNE8_chr12_39047872_ENST00000538596_length(amino acids)=353AA_BP=291 MKLGAGWGFSMKPPDRPAPGRTDRILGVMGGMLRACALPGQEGPPRRSPLGLVGTEPESERTEGDHRRDREHEVLAGALQPESYSIAGSE GSISASAASGLAAPSGPSSGLSSGPCSPGPPGPVSGLRRWLDHSKHCLSVETEADSGQAGPYENWMLEPALATGEELPELTLLTTLLEGP GDKTQPPEEETLSQAPESEEEQKKKALERSMYVLSELVETEKMYVDDLGQIVEGYMATMAAQGVPESLRGRDRIVFGNIQQIYEWHRDYF -------------------------------------------------------------- |
Top |
Fusion Gene PPI Analysis for ARHGEF25-CPNE8 |
| Go to ChiPPI (Chimeric Protein-Protein interactions) to see the chimeric PPI interaction in |
| Protein-protein interactors with each fusion partner protein in wild-type (BIOGRID-3.4.160) |
| Hgene | Hgene's interactors | Tgene | Tgene's interactors |
| - Retained PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
| - Lost PPIs in in-frame fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
| - Retained PPIs, but lost function due to frame-shift fusion. |
| Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
Related Drugs for ARHGEF25-CPNE8 |
| Drugs targeting genes involved in this fusion gene. (DrugBank Version 5.1.8 2021-05-08) |
| Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
Related Diseases for ARHGEF25-CPNE8 |
| Diseases associated with fusion partners. (DisGeNet 4.0) |
| Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Copyright 2021-Present -The University of Texas Health Science Center at Houston (UTHealth)
Web File Viewing | Emergency Information |Campus Carry|Site Policies